Cimetropium (Bromide)

Cimetropium (Bromide)

• CAS Number: 51598-60-8
• UNSPSC Description: Cimetropium Bromide (DA-3177) is a mAChR antagonist for long-term treatment of irritable bowel syndrome.
• Target Antigen: mAChR
• Type: Reference compound
• Related Pathways: GPCR/G Protein;Neuronal Signaling
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology; Neurological Disease
• Assay Protocol: https://www.medchemexpress.com/Cimetropium_Bromide.html
• Purity: 97.46
• Solubility: H2O : 50 mg/mL (ultrasonic)
• Smiles: C[N+]1([C@H]2[C@@H](O3)[C@@H]3[C@@H]1C[C@H](OC([C@@H](C4=CC=CC=C4)CO)=O)C2)CC5CC5.[Br-]
• Molecular Weight: 438.36
• References & Citations: [1]Identification of orally administered cimetropium bromide in the colon of the rat and its possible local spasmolytic effect.|[2]Saitoh N, et al. Characterization of antimuscarinic effect of cimetropium bromide in guinea pig ileum. J Smooth Muscle Res. 1997 Feb;33(1):1-9.
• Shipping Conditions: Room Temperature
• Storage Conditions: 4°C (Powder, sealed storage, away from moisture)
• Clinical Information: Launched